265 related articles for article (PubMed ID: 16542416)
1. Antibiotic susceptibility of Atopobium vaginae.
De Backer E; Verhelst R; Verstraelen H; Claeys G; Verschraegen G; Temmerman M; Vaneechoutte M
BMC Infect Dis; 2006 Mar; 6():51. PubMed ID: 16542416
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners.
De Backer E; Verhelst R; Verstraelen H; Alqumber MA; Burton JP; Tagg JR; Temmerman M; Vaneechoutte M
BMC Microbiol; 2007 Dec; 7():115. PubMed ID: 18093311
[TBL] [Abstract][Full Text] [Related]
4. Bacterial vaginosis, Atopobium vaginae and nifuratel.
Polatti F
Curr Clin Pharmacol; 2012 Feb; 7(1):36-40. PubMed ID: 22082330
[TBL] [Abstract][Full Text] [Related]
5. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to antibiotics of microorganisms related with recurrent bacterial vaginosis].
Shopova E; Nikolov A; Dimitrov A
Akush Ginekol (Sofiia); 2011; 50(7):20-1. PubMed ID: 22452174
[TBL] [Abstract][Full Text] [Related]
7. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.
Ferris MJ; Masztal A; Aldridge KE; Fortenberry JD; Fidel PL; Martin DH
BMC Infect Dis; 2004 Feb; 4():5. PubMed ID: 15018635
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility testing of Atopobium vaginae for dequalinium chloride.
Lopes dos Santos Santiago G; Grob P; Verstraelen H; Waser F; Vaneechoutte M
BMC Res Notes; 2012 Mar; 5():151. PubMed ID: 22429611
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis.
De Backer E; Dubreuil L; Brauman M; Acar J; Vaneechoutte M
Clin Microbiol Infect; 2010 May; 16(5):470-2. PubMed ID: 19548924
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure of bacterial vaginosis is not associated with higher loads of Atopobium vaginae and Gardnerella vaginalis.
Ferreira CST; Donders GG; Parada CMGL; Tristão ADR; Fernandes T; da Silva MG; Marconi C
J Med Microbiol; 2017 Aug; 66(8):1217-1224. PubMed ID: 28792372
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.
D'Aimmo MR; Modesto M; Biavati B
Int J Food Microbiol; 2007 Apr; 115(1):35-42. PubMed ID: 17198739
[TBL] [Abstract][Full Text] [Related]
12. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
[TBL] [Abstract][Full Text] [Related]
13. Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli.
Algburi A; Volski A; Chikindas ML
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25838136
[TBL] [Abstract][Full Text] [Related]
14. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
Simoes JA; Aroutcheva A; Heimler I; Shott S; Faro S
Am J Obstet Gynecol; 2001 Nov; 185(5):1186-90. PubMed ID: 11717655
[TBL] [Abstract][Full Text] [Related]
15. An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review.
Mendling W; Palmeira-de-Oliveira A; Biber S; Prasauskas V
Arch Gynecol Obstet; 2019 Jul; 300(1):1-6. PubMed ID: 30953190
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a sensitive system for analysis of human vaginal microbiota on the basis of rRNA-targeted reverse transcription-quantitative PCR.
Kurakawa T; Ogata K; Tsuji H; Kado Y; Takahashi T; Kida Y; Ito M; Okada N; Nomoto K
J Microbiol Methods; 2015 Apr; 111():93-104. PubMed ID: 25661498
[TBL] [Abstract][Full Text] [Related]
17. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
Nagaraja P
Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.
Delgado S; Flórez AB; Mayo B
Curr Microbiol; 2005 Apr; 50(4):202-7. PubMed ID: 15902467
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
Tomusiak A; Strus M; Heczko PB
Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
